Micrus Endovascular Company Profile

06:41 EDT 21st September 2018 | BioPortfolio

Micrus Endovascular is a medical device company formed in June 1996 with its corporate headquarters in San Jose, California. Micrus Endovascular manufactures and markets both implantable and disposable medical devices used in the treatment of cerebral vascular diseases. Our products are used by interventional neuroradiologists and neurosurgeons primarily to treat cerebral aneurysms in the brain responsible for hemorrhagic stroke, a significant cause of death in the United States. The Micrus product line is an endovascular system that enables a physician to gain access to the brain in a minimally invasive manner through the vessels of the circulatory system. We believe our products provide a safe and reliable alternative to more invasive neurosurgical procedures for treating aneurysms. Our proprietary, three-dimensional microcoils are unique in that they automatically deploy within the aneurysm, forming a scaffold that conforms to a wide diversity of aneurysm shapes and sizes. We also sell accessory devices and products used in conjunction with our microcoils. We rely extensively on our physician advisors to advise on our research and development efforts and to provide feedback on the clinical use of our products. Our advisors includes experts in interventional neuroradiology and cerebral vascular diseases. We regularly consult with our physician advisors regarding our research and development efforts, preclinical trials and clinical trials.


821 Fox Lane
San Jose
United States of America


Phone: (408) 433-1400
Fax: (408) 433-1401

News Articles [58 Associated News Articles listed on BioPortfolio]

‘Smart sheath’ uses AI to detect bleeds during endovascular procedures

A New Jersey hospital is testing an artificial intelligence (AI) device designed to alert clinicians to bleeding episodes during endovascular procedures.

Israeli endovascular startup names former Endologix exec as CEO

Kevin Mayberry was appointed CEO at Endospan, an Israeli startup that develops endovascular repair technologies for aortic ar -More- 

Endovascular Stroke Therapy: Real-World Outcomes Improving

Endovascular therapy for patients with acute ischemic stroke in the real world is at least as effective and safe as in randomized clinical trials, a new registry study from the Netherlands suggests. ...

Intact Vascular secures $20m funding for Tack endovascular system

Medical devices developer Intact Vascular has secured $20m funding for the Tack endovascular system, which is being developed to treat post-angioplasty dissections above the knee.

[Articles] Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial

Compared with a sham procedure, endovascular ultrasound renal denervation reduced ambulatory blood pressure at 2 months in patients with combined systolic–diastolic hypertension in the absence of me...

Endovascular treatment for acute ischaemic stroke in routine clinical practice: prospective, observational cohort study (MR CLEAN Registry)

AbstractObjectiveTo determine outcomes and safety of endovascular treatment for acute ischaemic stroke, due to proximal intracranial vessel occlusion in the anterior circulation, in routine clinical.....

Endovascular Therapy for Ischemic Stroke Effective in Real World Clinical Setting

Endovascular treatment is as safe and effective for acute ischemic stroke in the real world as it is in the setting of a clinical trial...

Gore unveils first patient implant endovascular stent graft for ascending aorta

The GORE ascending stent graft features a delivery system that is designed to enable for accurate, controlled deployment in complex anatomies As part of Arise study, the implant The post Gore unveils...

Drugs and Medications [0 Results]


PubMed Articles [398 Associated PubMed Articles listed on BioPortfolio]

Directional atherectomy is associated with better long term efficiency compared to angioplasty for common femoral artery occlusive disease in Rutherford 2 to 4 patients.

Despite increased interest in treating common femoral artery (CFA) with endovascular technology, there is little data regarding the long-term outcomes of different endovascular treatment modalities. W...

An alternative approach for treating a type Ia endoleak after conventional EVAR using the Nellix Endovascular Aneurysm Sealing.

To report the use of a Nellix endovascular aneurysm sealing (EVAS) device, to successfully treat a type Ia endoleak after an endovascular aortic repair (EVAR).

Endovascular treatments in combination with extracranial-intracranial bypass for complex intracranial aneurysms.

Although most intracranial aneurysms can be treated with microsurgery or endovascular procedure alone, a subset of aneurysms may require a combined approach. The purpose of this study was to assess th...

Open and Endovascular Repair of Popliteal Artery Aneurysms.

The purpose of this study was to report mid-term outcomes of open repair (OR) or endovascular repair (ER) of popliteal artery aneurysms (PAA) and assess if outcomes of patients have changed in the end...

Reinterventions following endovascular revascularization in elderly with critical limb ischemia; an observational study.

Endovascular first strategy for critical limb ischemia is widely accepted, because of the increasing patency rates and minimal invasive character, especially in elderly patients. Nonetheless, the impa...

Clinical Trials [355 Associated Clinical Trials listed on BioPortfolio]

Recovery by Endovascular Salvage for Cerebral Ultra-acute Embolism (RESCUE)-Japan RCT

The aim of this study is to clarify the efficacy of the endovascular treatment for acute ischemic stroke patients with large vessel occlusion and are not respond to intravenous recombinant...

MR-based Collateral Imaging to Predict Response to Endovascular Treatment of Stroke (FAST-COLL Study)

Based on the results of recent randomized controlled trials, current international guidelines recommend the initiation of endovascular treatment within 6 hours of symptom onset for acute i...

Endovascular Versus Open Repair of the Common Femoral Artery

Even though the indication for endovascular therapy has been enlarged, open repair of common femoral artery is still considered as the treatment of choice. A recent pilot study showed that...

Perfusion Imaging Evaluation for Ischemic Stroke on 6-24 Hours Undergoing Endovascular Thrombectomy

This study aims to evaluate the hypothesis that thrombectomy devices plus medical management leads to superior clinical outcomes in acute ischemic stroke patients at 90 days as compared to...

TX2® Low Profile TAA Endovascular Graft

The Zenith® TX2® Low Profile TAA Endovascular Graft study is a clinical trial approved by US FDA to evaluate the safety and effectiveness of the Zenith® TX2® Low Profile TAA Endovascul...

Companies [49 Associated Companies listed on BioPortfolio]

Micrus Endovascular Corporation

Micrus develops, manufactures and markets implantable and disposable medical devices for use in the treatment of cerebral vascular diseases. Micrus products are used by interventi...

Micrus Endovascular

Micrus Endovascular is a medical device company formed in June 1996 with its corporate headquarters in San Jose, California. Micrus Endovascular manufactures and markets both implantable and disposabl...

MAQUET Cardiovascular LLC

Patients with vascular conditions require flexible treatment options, including both traditional open vascular interventions and endovascular therapies. Current research indicates that surgeons use a ...

Aptus Endosystems, Inc.

Aptus Endosystems is a privately held medical technology company that has developed advanced technology for the endovascular treatment of aortic aneurysm disease. Founded in 2002,...


ev3 Inc. is a leading worldwide medical device company one hundred percent focused on catheter-based or endovascular technologies for the minimally invasive treatment of vascular disease and disorders...

More Information about "Micrus Endovascular" on BioPortfolio

We have published hundreds of Micrus Endovascular news stories on BioPortfolio along with dozens of Micrus Endovascular Clinical Trials and PubMed Articles about Micrus Endovascular for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Micrus Endovascular Companies in our database. You can also find out about relevant Micrus Endovascular Drugs and Medications on this site too.

Quick Search


Relevant Topics

Medical Devices
The role of medical devices in healthcare is essential.  The diversity and innovativeness of this sector contribute significantly to enhance the quality and efficacy of healthcare.  Covering a wide range of products, from simple bandages to the...

Blood is a specialized bodily fluid that delivers necessary substances to the body's cells (in animals) – such as nutrients and oxygen – and transports waste products away from those same cells.  In vertebrates, it is composed of blo...

Alzheimer's Disease
Of all the types of Dementia, Alzheimer's disease is the most common, affecting around 465,000 people in the UK. Neurons in the brain die, becuase  'plaques' and 'tangles' (mis-folded proteins) form in the brain. People with Al...

Corporate Database Quicklinks

Searches Linking to this Company Record